×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学... [131]
内容类型
期刊论文 [122]
会议论文 [9]
发表日期
2019 [11]
2018 [17]
2017 [16]
2016 [12]
2015 [13]
2014 [16]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共131条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 卷号: 176, 期号: 12
作者:
Qin, Xia
;
Hu, Longmiao
;
Fu, Jing
;
Miao, Zhenyuan
;
Li, Zheng-gang
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2019/12/05
The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging
期刊论文
ONCOLOGY REPORTS, 2019, 卷号: 41, 期号: 5
作者:
Wang, Shengfei
;
Niu, Xiaomin
;
Bao, Xiao
;
Wang, Qin
;
Zhang, Jianping
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
bone metastasis
phosphoinositide-3-kinase inhibitor
multimodality molecular imaging
multiparametric quantification
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 3
作者:
Xu, Song-Tao
;
Xi, Jun-Jie
;
Zhong, Wen-Zhao
;
Mao, Wei-Min
;
Wu, Lin
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/12/05
NSCLC
EGFR
tyrosine kinase inhibitor
gefitinib
adjuvant chemotherapy
Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis
期刊论文
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 卷号: 34, 期号: 2
作者:
Huang, Ruofan
;
Ge, Mengxi
;
Zhou, Xinli
;
Ji, Xiaoyu
;
Liao, Li
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/12/05
cerebrospinal fluid
EGFR
leptomeningeal metastasis
nonsmall cell lung cancer
tyrosine kinase inhibitor
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13
作者:
Zhang, Tengfei
;
Zhang, Lu
;
Xie, Yuancai
;
Li, Bing
;
Ma, Yafeng
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/05
EGFR alteration
ALK rearrangement
nonsmall cell lung cancer
EML4-ALK
tyrosine kinase inhibitor
Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells
期刊论文
ANTI-CANCER DRUGS, 2019, 卷号: 30, 期号: 1
作者:
He, Jian
;
Qi, Zihao
;
Zhang, Xiaofei
;
Yang, Yufei
;
Liu, Fei
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2019/12/05
barasertib
C-Myc
gastric cancer
glucose metabolism
ribosomal protein S7
Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations
期刊论文
MEDICAL SCIENCE MONITOR, 2019, 卷号: 25
作者:
Zhang, Hua-Hui
;
Mao, Jian-S.
;
Hu, Wei-F.
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/05
Genes, p16
Osteosarcoma
Polymorphism, Genetic
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer
期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:
Yu, Hui
;
Sun, Si
;
Hu, Xingjiang
;
Xia, Jinjing
;
Wang, Jialei
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/12/05
NSCLC
anaplastic lymphoma kinase
alectinib
tyrosine kinase inhibitor
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2
作者:
Xu, Xiaojing
;
Li, Hong
;
Peng, Ke
;
Yu, Yiyi
;
Chen, Lingli
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/12/05
epithelioid inflammatory myofibroblastic sarcoma
anaplastic lymphoma kinase
kinase inhibitor
crizotinib
Brigatinib
drug resistance
Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer
期刊论文
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 卷号: 78
作者:
Lu, Ji
;
Zhou, Kun
;
Yin, Xiaoxing
;
Xu, Han
;
Ma, Baojin
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/05
Epidermal growth factor receptor 2
Gatekeeper mutation
Tyrosine kinase inhibitor
Acquired resistance
Breast cancer
©版权所有 ©2017 CSpace - Powered by
CSpace